App ist vorübergehend nicht verfügbar

SMI Adviser

Beschreibung

Submit questions, access resources, and receive guidance from national experts in SMI.
Our mission is to advance the use of a person-centered approach to care that ensures people who have SMI find the treatment and support they need. For clinicians, we offer access to education, data, and consultations so you can make evidence-based treatment decisions. For individuals, families, friends, people who have questions, or people who care for someone with SMI, we offer access to resources and answers from a national network of experts. SMI Adviser is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and administered by the American Psychiatric Association (APA).
Funding for this initiative was made possible (in part) by Grant No. 1H79SM080818-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
*****
SMI Adviser is provided for general educational and informational purposes. It should not be construed as medical advice in connection with the care of a particular patient or as a statement of the standard of care. It is not necessarily inclusive of all potential treatments. The activities and materials offered through SMI Adviser should not be considered as providing the basis for any certification or authorization to prescribe or administer medication. SMI Adviser is not intended to be a substitute for independent professional medical advice, diagnosis or treatment. SMI Adviser does not endorse or recommend any pharmaceutical or other treatment as an appropriate course for any particular patient or condition. The advice of a physician or other qualified health provider should be obtained for a treatment recommendation or to answer any questions regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or seen on SMI Adviser. SMI Adviser is provided as-is and is not guaranteed to be correct, complete or current. APA makes no warranty, expressed or implied, about the accuracy, applicability, fitness, completeness or reliability of the information contained within SMI Adviser. APA assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of SMI Adviser or for any errors or omissions. The limitations applicable to the SMI Adviser consultation feature are set forth at: https://smiadviser.org/limitations-of-consultation
Ausblenden Mehr anzeigen...

Screenshots

SMI Adviser Häufige Fragen

  • Ist SMI Adviser kostenlos?

    Ja, SMI Adviser ist komplett kostenlos und enthält keine In-App-Käufe oder Abonnements.

  • Ist SMI Adviser seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet SMI Adviser?

    SMI Adviser ist kostenlos.

  • Wie hoch ist der Umsatz von SMI Adviser?

    Um geschätzte Einnahmen der SMI Adviser-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Südkorea noch nicht bewertet.
Bewertungsverlauf

SMI Adviser Bewertungen

Keine Bewertungen in Südkorea
Die App hat noch keine Bewertungen in Südkorea.

SMI Adviser Installationen

Letzte 30 Tage

SMI Adviser Umsatz

Letzte 30 Tage

SMI Adviser Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von SMI Adviser mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.

App-Informationen

This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.